TSE:VHI Vitalhub (VHI) Stock Price, News & Analysis C$10.16 -0.26 (-2.50%) As of 05/23/2025 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesBuy This Stock About Vitalhub Stock (TSE:VHI) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Vitalhub alerts:Sign Up Key Stats Today's RangeC$10.07▼C$10.3050-Day RangeC$8.99▼C$11.8652-Week RangeC$6.68▼C$12.34Volume107,054 shsAverage Volume131,972 shsMarket CapitalizationC$549.58 millionP/E Ratio165.25Dividend YieldN/APrice TargetC$12.90Consensus RatingBuy Company OverviewVitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions. Vitalhub Corp. was founded in 2010 and is based in Toronto, Canada.Read More… Vitalhub Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks36th Percentile Overall ScoreVHI MarketRank™: Vitalhub scored higher than 36% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingVitalhub has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageVitalhub has only been the subject of 2 research reports in the past 90 days.Read more about Vitalhub's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Vitalhub is 165.25, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.80.Price to Earnings Ratio vs. SectorThe P/E ratio of Vitalhub is 165.25, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.72.Price to Earnings Growth RatioVitalhub has a PEG Ratio of 1.18. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioVitalhub has a P/B Ratio of 4.02. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for VHI. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVitalhub does not currently pay a dividend.Dividend GrowthVitalhub does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Short InterestThere is no current short interest data available for VHI. News and Social Media1.8 / 5News Sentiment0.24 News SentimentVitalhub has a news sentiment score of 0.24. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Vitalhub this week, compared to 1 article on an average week.MarketBeat FollowsOnly 1 people have added Vitalhub to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, Vitalhub insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$255,750.00 in company stock and sold C$0.00 in company stock.Percentage Held by Insiders18.57% of the stock of Vitalhub is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 32.40% of the stock of Vitalhub is held by institutions.Read more about Vitalhub's insider trading history. Receive VHI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vitalhub and its competitors with MarketBeat's FREE daily newsletter. Email Address VHI Stock News HeadlinesVitalhub Corp. (TSE:VHI) Director Buys C$255,750.00 in StockMay 18, 2025 | insidertrades.comPublic market insider buying at Vitalhub (VHI)May 21 at 12:36 AM | theglobeandmail.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.May 24, 2025 | Porter & Company (Ad)Francis Shen Buys Handful Of Shares In VitalhubMay 21 at 12:36 AM | finance.yahoo.comFY2025 EPS Estimates for Vitalhub Reduced by Raymond JamesMay 16, 2025 | americanbankingnews.comFY2025 Earnings Forecast for Vitalhub Issued By CormarkMay 16, 2025 | americanbankingnews.comRaymond James Analysts Cut Earnings Estimates for VitalhubMay 15, 2025 | americanbankingnews.comEarnings call transcript: VitalHub Q1 2025 shows strong revenue growthMay 11, 2025 | uk.investing.comSee More Headlines VHI Stock Analysis - Frequently Asked Questions How have VHI shares performed this year? Vitalhub's stock was trading at C$11.27 on January 1st, 2025. Since then, VHI stock has decreased by 9.8% and is now trading at C$10.16. View the best growth stocks for 2025 here. How do I buy shares of Vitalhub? Shares of VHI stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of Vitalhub own? Based on aggregate information from My MarketBeat watchlists, some other companies that Vitalhub investors own include AST SpaceMobile (ASTS), Intel (INTC), Tempus AI (TEM), Recursion Pharmaceuticals (RXRX), Advanced Micro Devices (AMD), Broadcom (AVGO) and Genius Sports (GENI). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Health Information Services Sub-IndustryChemicals Current SymbolTSE:VHI CIKN/A Webvitalhub.com Phone416-699-0123FaxN/AEmployees2,250Year FoundedN/APrice Target and Rating Average Stock Price TargetC$12.90 High Stock Price TargetC$14.00 Low Stock Price TargetC$10.50 Potential Upside/Downside+27.0%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)C$0.06 Trailing P/E Ratio165.25 Forward P/E Ratio44.24 P/E Growth1.18Net IncomeC$3.35 million Net Margins5.11% Pretax MarginN/A Return on Equity3.01% Return on Assets3.81% Debt Debt-to-Equity Ratio0.28 Current Ratio2.33 Quick RatioN/A Sales & Book Value Annual SalesC$65.49 million Price / Sales8.39 Cash FlowN/A Price / Cash FlowN/A Book ValueC$2.53 per share Price / Book4.02Miscellaneous Outstanding Shares54,092,368Free FloatN/AMarket CapC$549.58 million OptionableNot Optionable Beta1.26 10 Stocks Set to Soar in Spring 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report This page (TSE:VHI) was last updated on 5/24/2025 by MarketBeat.com Staff From Our Partners$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredBig Oil’s big pivotThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vitalhub Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vitalhub With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.